A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors Bausch Health Companies; Ortho Dermatologics
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 02 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Jan 2019.
- 02 Mar 2018 Status changed from recruiting to active, no longer recruiting.